An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

NCT05123365 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Neoplasm
MPN
Essential Thrombocythemia
Polycythemia Vera
Myelofibrosis

Interventions

DRUG: N-Acetylcysteine

Sponsor

University of California, Irvine